- Home
- DCTH vs OSUR Comparison
DCTH vs OSUR Comparison
Compare DCTH & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- OSUR
- Stock Information
- Founded
- DCTH 1988
- OSUR 2000
- Country
- DCTH United States
- OSUR United States
- Employees
- DCTH N/A
- OSUR N/A
- Industry
- DCTH Medical/Dental Instruments
- OSUR Medical/Dental Instruments
- Sector
- DCTH Health Care
- OSUR Health Care
- Exchange
- DCTH Nasdaq
- OSUR Nasdaq
- Market Cap
- DCTH N/A
- OSUR 289.4M
- IPO Year
- DCTH N/A
- OSUR 1986
- Fundamental
- Price
- DCTH $11.43
- OSUR $3.87
- Analyst Decision
- DCTH Strong Buy
- OSUR Buy
- Analyst Count
- DCTH 4
- OSUR 3
- Target Price
- DCTH $21.50
- OSUR $6.67
- AVG Volume (30 Days)
- DCTH 496.1K
- OSUR 771.3K
- Earning Date
- DCTH 11-08-2024
- OSUR 11-06-2024
- Dividend Yield
- DCTH N/A
- OSUR N/A
- EPS Growth
- DCTH N/A
- OSUR N/A
- EPS
- DCTH N/A
- OSUR 0.15
- Revenue
- DCTH $22,644,000.00
- OSUR $224,263,000.00
- Revenue This Year
- DCTH $1,605.13
- OSUR N/A
- Revenue Next Year
- DCTH $111.67
- OSUR N/A
- P/E Ratio
- DCTH N/A
- OSUR $25.02
- Revenue Growth
- DCTH 945.91
- OSUR N/A
- 52 Week Low
- DCTH $2.60
- OSUR $3.72
- 52 Week High
- DCTH $12.88
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- DCTH 58.29
- OSUR 44.24
- Support Level
- DCTH $9.33
- OSUR $3.80
- Resistance Level
- DCTH $12.79
- OSUR $4.01
- Average True Range (ATR)
- DCTH 0.65
- OSUR 0.14
- MACD
- DCTH 0.20
- OSUR -0.00
- Stochastic Oscillator
- DCTH 65.31
- OSUR 41.67
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.